Newsline

Newsline , Society

AMAC Members Help Spark Landmark Investigation into Pharmacy Benefit Managers

Posted on Thursday, July 25, 2024
|
by AMAC Action
|
6 Comments
|
Print

July 25, 2024

Washington, D.C. – Following a robust nationwide outreach campaign from AMAC Members, the Federal Trade Commission (FTC) has released an interim report highlighting potentially unethical practices on the part of pharmacy benefit managers (PBMs) that could be forcing patients to pay more for prescription drugs while limiting patient choice.

PBMs are private intermediaries who are supposed to negotiate with drug manufacturers and pharmacies on behalf of insurance providers to deliver lower costs for patients. However, in recent years monopolistic practices and a lack of transparency have created cause for concern that PBMs may be abusing their position for their own gain while patients foot the bill.

From March through May 2022, the FTC opened a web page seeking comments on PBMs, likely anticipating hearing from doctors and patients. A total of 24,000 comments were submitted – 17,000 of them from AMAC members following a series of calls-to-action from AMAC Action.

Specifically citing the volume of comments received, the FTC announced an investigation into the business practices of the six leading PBM firms in the country. The agency’s interim report, released on July 9, noted that, “amidst increasing vertical integration and concentration,” PBMs “may be profiting by inflating drug costs and squeezing Main Street pharmacies.”

AMAC Action Senior Vice President Andy Mangione welcomed the results of the interim report saying, “We thank the FTC for conducting this investigation. The report’s findings validate our efforts seeking transparency and free-market reforms for pharmacy benefit managers that will likely lower drug costs for all Americans. We look forward to continuing this mission on behalf of the AMAC membership.”

When it comes to an issue as important as prescription drug price negotiations, patients deserve accountability and transparency. AMAC Action is proud to be an advocate for our members and hold PBMs to a high ethical standard for the critical role that they play in the drug supply chain.

Following the FTC investigation, the House Oversight and Accountability Committee also announced its own inquiry in an encouraging sign of bipartisan cooperation on this important issue. According to The Wall Street Journal, their report found that, “The drug middlemen that promise to control costs have instead steered patients toward higher-priced medicines and affiliated pharmacies.”

The House committee specifically unearthed emails from prominent PBMs “discouraging discussion” of using lower-priced alternatives to certain drugs in order to secure more kickbacks for PBMs.

Both Congress and the FTC have promised further action on this issue in the months ahead. AMAC Action will continue to press government officials for progress on this front and keep members informed on the latest developments.

You can read the entire FTC interim report HERE.

You can read the House Oversight Committee press release on its PBMs hearing HERE.

For media inquiries please contact Alyssa Lopresti: [email protected], 631-337-0106.

We hope you've enjoyed this article. While you're here, we have a small favor to ask...

The AMAC Action Logo

Support AMAC Action. Our 501 (C)(4) advances initiatives on Capitol Hill, in the state legislatures, and at the local level to protect American values, free speech, the exercise of religion, equality of opportunity, sanctity of life, and the rule of law.

Donate Now
Share this article:
Subscribe
Notify of
guest
6 Comments
Most Voted
Newest Oldest
Inline Feedbacks
View all comments
Cher
Cher
3 months ago

Thank you! This is a very important issue for those on only SS.

David Millikan
David Millikan
3 months ago

Well done AMAC members.

Rob citizenship
Rob citizenship
3 months ago

Very good article on an important issue — the matter of ethical standards in connection with pharmacies. At it’s. foundation Pharmacy is all about Chemistry — and that means how one material reacts to another material ( or chemical ). So, in the business sense of this matter the indications are that Pharmacy Benefit Management and Pharmacies are not reacting very well . So, adjustments need to be made with the addition of better Ethical Standards for the Pharmacy Benefit Managers and AMAC has been very responsible in efforts to achieve that goal . Praise to AMAC members and the Federal Trade Commission for going in the right direction with this matter The House Oversight and Accountability Committee did good too with their investigation — praise for them as well.

Richard
Richard
3 months ago

why do we need PBMs cant medicare go directly to the companys to get the best prices.

tim
tim
3 months ago
  • World Atlas (as of 2024) says: 46.50 % of US is Protestant with the remaining religions (53.50%) scattered over 12 classifications; the largest of which is apparently, Roman Catholic 20.80%) with Muslim at less than 1% (.90%). If we lose our freedom we’ll know where to look. Please vote. It’s only a lost cause if you listen to the minority. Please vote.
Tay
Tay
3 months ago

Good work Amac members!

Navy Blue AMAC Action Weekly Update
Donald Trump speaking to supporters at an immigration policy speech at the Phoenix Convention Center in Phoenix, Arizona.
“All the nations of the world — friend or foe — will find that America is strong, America is proud, and America is free.” (Official White House Photo by Shealah Craighead)

Stay informed! Subscribe to our Daily Newsletter.

"*" indicates required fields

6
0
Would love your thoughts, please comment.x
()
x

Subscribe to AMAC Daily News and Games